Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20143
20181
20192
20203
20213
20222
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8
Completed5
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
BeOne Medicines2
Gilead Sciences2
Incyte Corporation2
BeiGene1
Celgene1
Eli Lilly and Company1
Genmab1
Janssen Research & Development, LLC1
Jichi Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone19
Lymphoma, Follicular18
Lymphoma, Mantle-Cell10
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Non-Hodgkin8
Leukemia, Lymphocytic, Chronic, B-Cell7
Waldenstrom Macroglobulinemia7
Lymphoma, B-Cell5
Lymphoma3
Neoplasms3

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.